Literature DB >> 16411055

A pooled analysis of bladder cancer case-control studies evaluating smoking in men and women.

Diana Puente1, Patricia Hartge, Eberhard Greiser, Kenneth P Cantor, Will D King, Carlos A González, Sylvaine Cordier, Paolo Vineis, Elsebeth Lynge, Jenny Chang-Claude, Stefano Porru, Anastasia Tzonou, Karl-Heinz Jöckel, Consol Serra, Martine Hours, Charles F Lynch, Ulrich Ranft, Jürgen Wahrendorf, Debra Silverman, Francisco Fernandez, Paolo Boffetta, Manolis Kogevinas.   

Abstract

OBJECTIVE: A recent study suggested that risk of bladder cancer may be higher in women than in men who smoked comparable amounts of cigarettes. We pooled primary data from 14 case-control studies of bladder cancer from Europe and North America and evaluated differences in risk of smoking by gender.
METHODS: The pooled analysis included 8316 cases (21% women) and 17,406 controls (28% women) aged 30-79 years. Odds ratios (ORs) and 95% confidence intervals (95% CI) for smoking were adjusted for age and study. Exposure-response was evaluated in a stratified analysis by gender and by generalized additive models.
RESULTS: The odds ratios for current smokers compared to nonsmokers were 3.9 (95% CI 3.5-4.3) for males and 3.6 (3.1-4.1) for females. In 11 out of 14 studies, ORs were slightly higher in men. ORs for current smoking were similar for men (OR = 3.4) and women (OR = 3.7) in North America, while in Europe men (OR = 5.3) had higher ORs than women (OR = 3.9). ORs increased with duration and intensity in both genders and the exposure-response patterns were remarkably similar between genders.
CONCLUSION: These results do not support the hypothesis that women have a higher relative risk of smoking-related bladder cancer than men.

Entities:  

Mesh:

Year:  2006        PMID: 16411055     DOI: 10.1007/s10552-005-0389-0

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  8 in total

1.  An examination of male and female odds ratios by BMI, cigarette smoking, and alcohol consumption for cancers of the oral cavity, pharynx, and larynx in pooled data from 15 case-control studies.

Authors:  Jay H Lubin; Joshua Muscat; Mia M Gaudet; Andrew F Olshan; Maria Paula Curado; Luigino Dal Maso; Victor Wünsch-Filho; Erich M Sturgis; Neonilia Szeszenia-Dabrowska; Xavier Castellsague; Zuo-Feng Zhang; Elaine Smith; Leticia Fernandez; Elena Matos; Silvia Franceschi; Eleonora Fabianova; Peter Rudnai; Mark P Purdue; Dana Mates; Qingyi Wei; Rolando Herrero; Karl Kelsey; Hal Morgenstern; Oxana Shangina; Sergio Koifman; Jolanta Lissowska; Fabio Levi; Alexander W Daudt; Jose Eluf Neto; Chu Chen; Philip Lazarus; Deborah M Winn; Stephen M Schwartz; Paolo Boffetta; Paul Brennan; Ana Menezes; Carlo La Vecchia; Michael McClean; Renato Talamini; Thangarajan Rajkumar; Richard B Hayes; Mia Hashibe
Journal:  Cancer Causes Control       Date:  2011-07-09       Impact factor: 2.506

2.  Best practice in the treatment of nonmuscle invasive bladder cancer.

Authors:  Anastasios Anastasiadis; Theo M de Reijke
Journal:  Ther Adv Urol       Date:  2012-02

3.  Association between smoking and risk of bladder cancer among men and women.

Authors:  Neal D Freedman; Debra T Silverman; Albert R Hollenbeck; Arthur Schatzkin; Christian C Abnet
Journal:  JAMA       Date:  2011-08-17       Impact factor: 56.272

4.  Lifetime exposure to arsenic in drinking water and bladder cancer: a population-based case-control study in Michigan, USA.

Authors:  Jaymie R Meliker; Melissa J Slotnick; Gillian A AvRuskin; David Schottenfeld; Geoffrey M Jacquez; Mark L Wilson; Pierre Goovaerts; Alfred Franzblau; Jerome O Nriagu
Journal:  Cancer Causes Control       Date:  2010-01-19       Impact factor: 2.506

5.  Urothelial Carcinoma of the Urinary Bladder in Young Adults: Presentation, Clinical behavior and Outcome.

Authors:  Michael Nomikos; Athanasios Pappas; Maria-Emmanouela Kopaka; Stavros Tzoulakis; Ioannis Volonakis; Georgios Stavrakakis; Georgios Avgenakis; Ploutarchos Anezinis
Journal:  Adv Urol       Date:  2011-11-22

6.  Distinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers.

Authors:  Holger Schwender; Silvia Selinski; Meinolf Blaszkewicz; Rosemarie Marchan; Katja Ickstadt; Klaus Golka; Jan G Hengstler
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

Review 7.  Modifiable risk factors for the prevention of bladder cancer: a systematic review of meta-analyses.

Authors:  Abdulmohsen H Al-Zalabani; Kelly F J Stewart; Anke Wesselius; Annemie M W J Schols; Maurice P Zeegers
Journal:  Eur J Epidemiol       Date:  2016-03-21       Impact factor: 8.082

8.  Expression pattern of p53-binding protein 1 as a new molecular indicator of genomic instability in bladder urothelial carcinoma.

Authors:  Katsuya Matsuda; Tatsuhiko Kawasaki; Yuko Akazawa; Yuhmi Hasegawa; Hisayoshi Kondo; Keiji Suzuki; Masachika Iseki; Masahiro Nakashima
Journal:  Sci Rep       Date:  2018-10-19       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.